Noreen Brar
Sr. Strategist at R/GA Ventures
San Francisco Bay Area
Overview
Work Experience
Sr. Strategist
2021 - Current
R/GA Ventures is R/investment GA's arm that assists industry leaders in capitalizing on disruptive technologies.
Associate
2020 - 2021
Analyst
2019 - 2020
Plug & Play Topeka is a Venture Capital company that offers corporate Innovation, open Innovation, and accelerator Programs.
Investment Principal
2020 - 2021
- Sourced and evaluated startups to assess company fit, led diligence calls, and completed due diligence on 6 startups resulting in investment - Assisted portfolio companies with conceptualizing new marketing tactics and business opportunities within women's health - Led SteelSky Fellows/Internship program managed 30+ students across 3 universities to provide portfolio support
SteelSky Ventures is an early stage VC fund investing in Women’s Health.
Analyst
2018 - 2019
Patented SPEAR platform removes immunilogical barriers to generate off-the-shelf and organ replacements to avoid long-term medication, repeat transplants and associated patient deaths. • Lead market research on relevant competitors in targeted delivery of diagnostic and therapeutic agents, identify market opportunities, and define current product • Guided product development by conducting thorough investigations into the FDA approval process • Conducted customer interviews, analyzed market penetration points and developed future acquisition strategy
Vivita Technologies develops biomaterials for regenerative medicine, intending to alleviate the scarcity of donor organs and tissues.
Raised $1,500,000.00 from National Heart, Lung and Blood Institute.
Consultant
2015 - 2019
Targeted delivery of chemotherapy for pancreatic cancer patients • Organized and collected data, to derive insights and provide actionable recommendations for product development • Crafted marketing strategies for targeted doses of chemotherapy to the peripheral vasculature • Designed improved internal processes to reduce on-boarding time for future board members
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
Raised $32,319,774.00 from Boston Scientific, Astia Angels, b2venture and Golden Seeds.
Undergraduate Student Researcher
2016 - 2018
Under Dr. Annaliese Franz, emphasis on organic chemistry
Undergraduate Researcher
2017 - 2018
Under Dr. Amber Boydstun, emphasis on American Politics